Figure 1.
Figure 2.
Multiple logistic regression analysis exploring the association between different predictors and aggressive medical care in the last month of life_
| P | OR | 95% CI | |
|---|---|---|---|
| Gender (male = REF) | 0.61 | 0.93 | 0.72 – 1.21 |
| Age at death* | < 0.001 | 0.96 | 0.95 – 0.97 |
| Year of death | 0.12 | 1.06 | 0.98 – 1.15 |
| Prognosis of cancer | |||
| Low (REF) | / | / | / |
| Intermediate | 0.30 | 1.24 | 0.83 – 1.85 |
| High | 0.85 | 1.05 | 0.64 – 1.73 |
| Type of cancer | |||
| Others (REF) | / | / | / |
| Gastrointestinal | 0.41 | 0.83 | 0.53 – 1.30 |
| Lung | 0.20 | 1.34 | 0.86 – 2.08 |
| Breast | 0.43 | 1.24 | 0.73 – 2.09 |
| Gynecological | 0.04 | 0.52 | 0.28 – 0.97 |
| Urogenital | 0.55 | 0.87 | 0.55 – 1.38 |
| Aggressive oncological treatment (Yes vs. No) | < 0.001 | 1.84 | 1.47 – 2.30 |
| Specialist palliative care (No = REF) | < 0.001 | 0.25 | 0.15 – 0.40 |
Multiple logistic regression analysis exploring the association between different predictors and the use of aggressive anticancer treatment in the last month of life_
| P | OR | 95% CI | |
|---|---|---|---|
| Gender (male = REF) | 0.53 | 0.92 | 0.71 – 1.19 |
| Age at death* | < 0.001 | 0.96 | 0.95 – 0.97 |
| Year of death | 0.12 | 1.06 | 0.99 – 1.15 |
| Prognosis of cancer | |||
| Low (REF) | / | / | / |
| Intermediate | 0.22 | 1.28 | 0.86 – 1.92 |
| High | 0.80 | 1.07 | 0.65 – 1.75 |
| Type of cancer | |||
| Others (REF) | / | / | / |
| Gastrointestinal | 0.38 | 0.82 | 0.53 – 1.28 |
| Lung | 0.20 | 1.34 | 0.86 – 2.07 |
| Breast | 0.35 | 1.28 | 0.76 – 2.15 |
| Gynecological | 0.05 | 0.53 | 0.28 – 1.00 |
| Urogenital | 0.87 | 0.87 | 0.55 – 1.39 |
| Specialist palliative care (No = REF) | < 0.001 | 0.19 | 0.12 – 0.31 |